Watch/Listen

SCAI 2025 Program Chair Binita Shah, MD, MS, FSCAI, shares some of the cutting-edge educational topics and enriching sessions planned for the meeting.

Drs Mort Kern and Arnold Seto, and Bailey Estes, AGNP-C, discuss the results of 4 trials presented at ACC.25 and how decision making in the cath lab will be affected by the trial results.

Incoming SCAI President Srihari S. Naidu, MD, FSCAI, shares what he most values about the Society, his goals in founding the Emerging Leaders Mentorship (ELM) program, and plans for the upcoming year.

How can we design peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI) trials that actually reflect the patients we treat every day? In his CRT 2025 presentation, Dr. Zola M. N'Dandu addressed the urgent need to...

At CRT 2025 in Washington, D.C., Dr. Morton J. Kern discussed his prediction around the FLAVOUR II trial: would AI-driven angioFFR prove to be noninferior to intravascular ultrasound (IVUS) in guiding percutaneous coronary intervention for...

Dr. Sacharias von Koch presented an analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) on the Prevail™ coronary paclitaxel drug-coated balloon (DCB) from Medtronic as a late-breaking clinical trial at...

Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...

Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).